RT234 - vardenafil inhalation powder ( DrugBank: Vardenafil )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04266197 (ClinicalTrials.gov)	September 25, 2020	22/1/2020	Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study	A Phase 2b, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise ...	Pulmonary Arterial Hypertension	Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere ...	Respira Therapeutics, Inc.	NULL	Recruiting	18 Years	80 Years	All	86	Phase 2	United States;Serbia
2	NCT05343637 (ClinicalTrials.gov)	July 30, 2019	4/4/2022	A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hyperten ...	A Phase 2a, Dose Escalation Study to Evaluate the Effect of RT234 on Cardiopulmonary Hemodynamics in ...	Pulmonary Arterial Hypertension	Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: RS01 dry powder inhaler (RS ...	Respira Therapeutics, Inc.	NULL	Completed	18 Years	80 Years	All	14	Phase 2	Australia

First Previous1Next Last